API Roundtable - Pharmaceutical Outsourcing
Currently pharma’s innovators face a number of key issues sourcing APIs to support their overall drug strategies with regulatory knowledge and scientific expertise at the forefront. The embedded CDMO model (self-contained organizations that work within larger companies), offers drug developers access to both the regulatory and scientific expertise of its parent company.
API manufacturers should express reliability as their most important quality - This means being reliable in terms of experience and capabilities in quality and compliance, as well as having excellent project management and collaboration practices in place within the company.
Nicole Strauss, Pipeline and Innovation Lead at Pfizer CentreOne, took part in a roundtable with Pharmaceutical Outsourcing to discuss the key trends around Active Pharmaceutical Ingredients (APIs) with input from other industry leaders.